| CAS ID: | 557795-19-4 |
| Molecular Formula: | C22H27FN4O2 |
| Molecular Weight: | 398.5 g/mol |
| Monoisotopic Mass: | 398.2118 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | SUTENT | SUNITINIB | Sutent | SU-11248 | SUNITINIB MALATE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12- | See All |
| InChI Key: | WINHZLLDWRZWRT-ATVHPVEESA-N | |
| Smiles: | CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C | See All |
| Molfile: | Download |
Reference Record 1
| PubMed ID | 27439438 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | fibroblasts accumulation, EMT | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Smad2/3 | ||
Trial Record 1
| ClinicalTrial ID | NCT01215565 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | October 6, 2010 | Last Verified | March 13, 2014 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||